Cimicifugae racemosae rhizoma

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 04.04.2024

Dieser Artikel auf Deutsch

Synonym(s)

bugweed, grape silver candle rootstock; Cimcifuga; Women's Root

Definition
This section has been translated automatically.

Extract from the root system (rhizome+roots) of black co hosh (Cimicifuga racemosa), which is used for medicinal purposes. The root extracts of black cohosh, also known as women's root, were already used in the 18th century to treat gynecological diseases.

HMPC monograph: Well-established use: Menopausal symptoms, hot flushes, excessive sweating.
Approved, supported by clinical data: Psychological and neurovegetative symptoms during the menopause.
ESCOP monograph: Climacteric symptoms such as hot flushes, profuse sweating, sleep disorders, nervous irritability
Commission e-monograph: Premenstrual, dysmenorrheal, climacteric-related neurovegetative symptoms.

Pharmacodynamics (Effect)
This section has been translated automatically.

The active ingredients of the root extracts are actein, a glycoside with a hypotensive effect, as well as the terpene derivative (tetracyclic triterpene), cymogonol monoxyloside (cimicifugoside), cimiracemoside and cimegenol-3-O-alpha-L-arabinoside = typical lead substance for Cimicifuga racemosa). Furthermore, the root extract contains tannins, salicylic and gallic acid as well as various alkaloids (cytisine, cytisine, cytosine). Alkaloids (cytisine) are also contained in the root extract.

The use of ready-made preparations is strongly recommended, not tea infusions!

Spectrum of action
This section has been translated automatically.

The extract has a weak estrogenic effect; it also has an anti-inflammatory, antipyretic and sedative effect.

The ingredients bind to estrogen receptors (competition with estradiol and hence the name "phyto-SERMs").

Indication
This section has been translated automatically.

Limited indication
This section has been translated automatically.

Breast cancer only after consultation with a doctor, liver dysfunction, vaginal bleeding when taking

Pregnancy/nursing period
This section has been translated automatically.

Do not use during pregnancy or while breastfeeding.

Undesirable effects
This section has been translated automatically.

Liver toxicity, allergic skin reactions(urticaria, itching, exanthema), facial edema, peripheral edema, gastrointestinal disorders: dyspepsia, diarrhea.

Contraindication
This section has been translated automatically.

Combination with estrogens, pregnancy and breastfeeding in the absence of data; allergy to one of the ingredients

Preparations
This section has been translated automatically.

Femikliman® uno film-coated tablets (ED 6.5mg), 1-0-0

Feminon C® hard capsules (ED 6.5mg), 1-0-0

Klimadybin uno ® Flem tablets (ED 6.5mg), 1-0-0

Remifemin tablets (ED 2.5mg), 1-0-1

Combination preparation:

Remifemin plus® film-coated tablets, 1(2)-0-1(2) approved preparation since 01.08.2018